Your browser doesn't support javascript.
loading
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program.
Massimo, Andreoni; Teti, Elisabetta; Antinori, Andrea; Milazzoi, Laura; Sollima, Savatore; Rizzardini, Giuliano; Di Biagio, Antonio; Saracino, Annalisa; Bruno, Raffaele; Borghi, Vanni; De Luca, Andrea; Cattelan, Annamaria; Hasson, Hamid; Taliani, Gloria; Monforte, Antonella D'Arminio; Mastroianni, Claudio Maria; Di Perri, Giovanni; Bigoni, Sara; Puoti, Massimo; Spinetti, Angiola; Gori, Andrea; Boffa, Nicola; Bruno, Cacopardo; Giacometti, Andrea; Parruti, Giustino; Vullo, Vincenzo; Chirianni, Antonio; Pennica, Alfredo; Pasquazzi, Caterina; Segala, Daniela; Sarmati, Loredana.
Afiliação
  • Massimo A; Clinical Infectious Diseases, Department. of Systems Medicine, Tor Vergata University, Rome, Italy.
  • Teti E; Clinical Infectious Diseases, Department. of Systems Medicine, Tor Vergata University, Rome, Italy.
  • Antinori A; Clinical Department, National Institute for Infectious Diseases, INMI "L. Spallanzani″, Rome, Italy.
  • Milazzoi L; Department of Biomedical and Clinical Science, University of Milan,Milan, Italy.
  • Sollima S; Department of Biomedical and Clinical Science, University of Milan,Milan, Italy.
  • Rizzardini G; Department of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy, and School of Clinical Medicine, Faculty of Health Science, University of the Witwatersrand, Johannesburg, South Africa.
  • Di Biagio A; Infectious Disease Clinic, IRCCS University Hospital, San Martino IST, Genova, Italy.
  • Saracino A; Institute of Infectious Disease, University of Bari, Bari, Italy.
  • Bruno R; Division of Infectious and Tropical Diseases, IRCCS Policlinico San Matteo, Pavia, Italy.
  • Borghi V; Infectious Diseases Clinic, University Hospital, Modena, Italy.
  • De Luca A; Department of Internal and Specialty Medicine University Infectious Diseases Unit, AOU Senese, Siena, Italy.
  • Cattelan A; Department of Infectious and Tropical Diseases, University Hospital, Padova, Italy.
  • Hasson H; Department of Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy.
  • Taliani G; Department of Clinical Medicine, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
  • Monforte AD; Clinic of Infectious and Tropical Diseases, Department of Health Sciences, University of Milan, Milan, Italy.
  • Mastroianni CM; Infectious Diseases Unit, Sapienza University of Rome, Latina, Italy, and Department of Public Health and Infectious Diseases, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
  • Di Perri G; Unit of Infectious Diseases, University of Turin, Department of Medical Sciences, "Amedeo di Savoia″ Hospital, Turin, Italy.
  • Bigoni S; Division of Infectious Diseases, AO Papa Giovanni XXIII, Bergamo, Italy.
  • Puoti M; Division of Infectious Diseases, AO Niguarda Ca' Granda Hospital, Milan, Italy.
  • Spinetti A; Division of Infectious and Tropical Diseases, University of Brescia and Spedali Civili General Hospital, Brescia, Italy.
  • Gori A; Division of Infectious Diseases, Department of Internal Medicine, "San Gerardo″ Hospital, University of Milan-Bicocca, Milan, Italy.
  • Boffa N; First Division of Infectious Diseases, S. Giovanni di Dio e Ruggi d'Aragona Hospital, Salerno, Italy.
  • Bruno C; Division of Infectious Diseases, Department of Clinical and Experimental Medicine, ARNAS Garibaldi Hospital, University of Catania, Catania, Italy.
  • Giacometti A; Infectious Diseases Unit, Department of Biomedical Sciences and Public Health, Marche Polytechnic University c/o Ospedali Riuniti, Ancona, Italy.
  • Parruti G; Infectious Disease Unit, Pescara General Hospital, Pescara, Italy.
  • Vullo V; Department of Public Health and Infectious Diseases, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
  • Chirianni A; III U.O.C. P.O. Cotugno, AORN Ospedali dei Colli, Naples, Italy.
  • Pennica A; Clinical Infectious Diseases, Sant'Andrea Hospital - Sapienza University of Rome, Rome, Italy.
  • Pasquazzi C; Clinical Infectious Diseases, Sant'Andrea Hospital - Sapienza University of Rome, Rome, Italy.
  • Segala D; Unit of Infectious Diseases, University Hospital of Ferrara, Ferrara, Italy.
  • Sarmati L; Clinical Infectious Diseases, Department. of Systems Medicine, Tor Vergata University, Rome, Italy.
Clin Infect Dis ; 64(5): 680-683, 2017 03 01.
Article em En | MEDLINE | ID: mdl-28011605
ABSTRACT
Patients co-infected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are at high risk of liver disease progression. We report a favorable safety profile and SVR12 rates of 96.7% among HIV/HCV co-infected patients participating in an Italian compassionate-use program of ombitasvir/paritaprevir/ritonavir + dasabuvir (OBV/PTV/r + DSV) ± ribavirin (RBV).
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália